PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

14
PROPOSED DRAFT PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY An "Undefined Illness"? 10/18/2014

description

A proposed draft for discussion purposes only. To be used by persons with Multiple Chemical Sensitivity (MCS) and their medical team to start a dialogue on proper care. (October 2014)

Transcript of PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

  • PROPOSED DRAFT

    PROTOCOL CARE FOR PATIENTS

    WITH MULTIPLE CHEMICAL

    SENSITIVITIES OR CHEMICAL

    INJURY An "Undefined Illness"?

    10/18/2014

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    1

    A PERSON WITH MULTIPLE CHEMICAL SENSITIVITY (MSC) SHOULD READ THIS DRAFT PROTOCOL AND DISCUSS IT

    THOROUGHLY WITH HIS/HER PHYSICIAN AND ATTENDING CAREGIVER(S) TO MAKE ANY NECESSARY MODIFICATIONS

    OR THE LIKE. DRAFT PROTOCOL STARTS ON

    PAGE SIX (6).

    WHEN ENCOUNTERING A PERSON (prospective patient) with (MCS) or Chemical Injury or Chemical Intolerance, this is what you should know:

    Overview | Multiple Chemical

    Sensitivity (MCS) is the name given to

    a syndrome in which a sufferer

    experiences multiple symptoms upon

    exposure to minute amounts of

    everyday chemicals. There is currently

    no officially recognized definition for

    MCS. This is due to the fact that it is

    becoming pervasive but the political

    will to pin point the causes to petro-

    based compounds used in many

    common consumer products is

    lacking. Thus, it is claimed that very

    little is known about it, especially the

    mechanisms involved with the onset

    of symptoms.

    To circumvent the "elephant in the

    room," there are theories to suggest

    a possible role for a hypersensitive

    central nervous system, immune

    dysfunction and impaired

    detoxification by liver enzymes. Some

    medical professionals, and even

    organizations, continue to insist that

    the syndrome is psychological in

    origin, even in the face of a growing

    amount of evidence from studies that

    show clear abnormalities in people

    with MCS on exposure to normally

    safe levels of chemicals. Through

    1999 there were a total of 618

    scientific articles, editorials, books,

    book chapters and reports relating to

    MCS. Of these, 308 supported an

    organic/physiological basis for

    symptoms whereas only 137

    supported a psychological

    interpretation.

    Although there is no definition

    universally accepted by the

    established medical institutions since

    1999, MCS experts (Bartha et al 1999)

    have come to a consensus on the

    criteria for diagnosis, and thus far

    these criteria remain unrefuted in the

    published literature.

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    2

    These criteria are as follows:

    The symptoms are reproducible

    with [repeated chemical] exposure.

    The condition is chronic.

    Low levels of exposure [lower than

    previously or commonly tolerated]

    result in manifestations of the

    syndrome.

    The symptoms improve or resolve

    when the triggers are removed.

    Responses occur to multiple

    chemically unrelated substances.

    Symptoms involve multiple organ

    systems.

    MCS/Toxic Injury is NOT a result of

    an allergen. It is a result of exposure

    to a toxin/toxicant.

    In brief, MCS is an acquired chronic

    disorder characterized by recurrent

    symptoms in response to exposure

    to multiple, unrelated chemicals

    ("chemical cocktails") in the

    environment. The symptoms

    generally occur in one of four

    categories: central nervous system,

    circulatory, respiratory, and hepatic,

    including liver and spleen.

    Moreover, as of 2011, the prevalence

    of MCS of the U.S. population was at

    13 percent (approximately 40

    million). This calls for informed

    medical help for people with

    chemical sensitivities. Missed

    diagnosis of chemical sensitivities

    may result in incorrect treatment

    and possible iatrogenic

    harm resulting from the activity of

    physicians; said of any adverse cond

    ition in apatient resulting from treat

    ment by a physician or surgeon.

    Symptoms | Many MCS sufferers can

    trace the start of their illness to an

    acute exposure to highly toxic

    chemicals (Gulf War veterans, and

    farmers using pesticides for example).

    For other sufferers the illness

    develops over a long period of time

    most likely involving chronic low level

    exposure to chemical substances.

    Although MCS can occur on its own, a

    large number of sufferers also suffer

    from CFS, Fibromyalgia and other

    related disorders. This obviously

    points to the possibility that all these

    illnesses are part of the same

    underlying process and likely have

    common causes.

    MCS is a chronic condition with the

    patient usually experiencing some

    level of "unwellness" all the time.

    However, patients have an acute

    reaction when exposed to minute

    amounts of the chemicals to which

    they are sensitive. Often the level of a

    chemical that triggers a reaction may

    be so low that the sufferer cannot

    even smell it.

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    3

    Common symptoms of MCS upon

    exposure:

    Fatigue

    Headaches

    Disorientation

    Dizziness and faintness

    Flu-like symptoms

    Memory loss

    Visual problems

    Nausea

    Irregular or rapid heartbeat

    Muscle and/or joint pain

    Gastrointestinal problems

    Mood disturbances such as

    depression/anxiety/irritability

    Short-term altered mental status

    Asthma/Breathing Problems

    Rashes

    Difficulty concentrating

    Flushes

    Most sufferers have a distinct reaction

    upon every exposure. It is common to

    first experience dizziness,

    disorientation, rapid heartbeat and

    mood changes followed by flu-like

    illness and muscle/joint aches. In

    severe cases, the flu-like illness and

    aching can persist for days.

    Triggers | Reactions in MCS are

    triggered by a vast array of everyday

    chemicals from perfume to diesel

    exhaust. The common ingredients in

    most of these chemical products are

    hydrocarbon based volatile organic

    chemicals (VOCs). Phenols (containing

    benzene) are commonly implicated.

    With everyday cosmetic and

    household chemical products, it is

    generally the addition of perfume that

    makes them bad news for MCS

    sufferers. Typically a sufferer will

    notice a sensitivity to one or two

    things to start with, perfume and

    cigarette smoke for example, and then

    will rapidly become sensitized to

    more and more chemical sources over

    a relatively short period of time. The

    reasons for this common occurrence

    are unknown but it is clearly

    something that needs to be

    investigated.

    Common triggers in MCS are

    pesticides (e.g., organophosphates

    and organochloridesDDT,

    chlordane, lindane, dieldrin)

    fragrances (perfume) (benzaldehyde,

    benzyl acetate, benzyl alcohol,

    camphor, ethanol, ethylacetate,

    limonene, linalool, a-pinene, g-

    terpinene, a-terpineol,

    dichlorobenzene); note that all of

    these chemicals are known to have

    negative health consequences, mainly

    due to effects on the central nervous

    system

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    4

    gasoline | vapors cause central

    nervous system depression, including

    eye and respiratory irritation,

    dizziness, headache, drowsiness, and

    incoordination

    vehicle exhaust | major exhaust

    fumes include carbon monoxide,

    nitrogen dioxide, sulphur dioxide,

    benzene, formaldehyde, polycylic

    hydrocarbons, and suspended

    particles (PM-10)

    household cleaning products,

    dishwasher detergent, including

    laundry liquid/powder, fabric

    softener, air fresheners, and

    bathroom/kitchen detergents |

    common chemicals include diethyl

    phthalate, toluene, hexane/xylene

    personal care products & cosmetics

    including shower gels and liquid

    soap, nail varnish, hair styling

    products, hair conditioners, sun

    lotions, scented soaps | some of the

    common chemicals include cocoamide

    DEA, sodium lauryl sulfate, acetone,

    benzaldehyde.

    Other triggers include cigarette

    smoke, natural gas, new carpets made

    with benzene derivatives,

    formaldehyde and the like, particle

    board, marker pens, soft plastics,

    newspapers/magazine, paint, varnish,

    solvents, glues/adhesive, food

    additives and preservatives,

    medications, unfiltered waterand

    more.

    This list is not all inclusive.

    Impact on Quality of Life | As a

    devastating illness, an MCS sufferer

    typically becomes more and more

    isolated and withdrawn as they simply

    cant be around people (wearing

    perfume, deodorant etc.) or in public

    spaces where chemicals are routinely

    used. MCS sufferers often lose their

    jobs as they cannot tolerate the

    chemicals in the work environment,

    and relationships often break down as

    the partner is unable to understand or

    adapt to living without the use of

    common chemical products. To add

    insult to injury, because of the current

    medical confusion over the illness,

    patients often have to endure being

    labelled as attention seekers or

    hypochondriacs, as well as having to

    fight, often in court, to be granted

    disability benefits and appropriate

    housing.

    NOTE: If the primary doctor doubts

    that Multiple Chemical Sensitivity is

    NOT physiological and believes the

    roots are psychological, that doctor

    is not an appropriate health care

    provider for the person with MCS.

    Such a doctor can do more harm

    than good and needs to do further

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    5

    research on recent findings that

    point to physiological origins.

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    6

    DRAFT

    PROTOCOL

    o Reassure the patient that you

    understand he/she is sensitive

    to chemicals and will work with

    him/her in providing care.

    o Be sure to ask what exposure(s)

    she/she recently encountered.

    o Be sure to ask what the patient

    is sensitive to, including his/her

    history of reactions to various

    drugs you may consider to

    administer.

    NOTE: Persons with MCS are

    the experts related to their

    own needs and requirements.

    Therefore, it is important to

    have the patient involved in

    the development of their care

    plan.

    A comprehensive assessment is

    required, and the medical

    history may be extensive as MCS

    affects many systems.

    o Take into consideration the five

    stages of grief or loss of good

    health and determine which

    stage the patient is in regarding

    his/her condition

    (1) denial and isolation

    (2) anger

    (3) bargaining

    (4) depression

    (5) acceptance

    o Carefully note environmental

    sensitivities, food and drug

    allergies and their reactions.

    Note how the patient copes with

    his/her MCS as it varies

    dependent on the actual

    sensitivities specific to that

    patient. Include what specific

    equipment they use, their usual

    medications or remedies,

    alternative measures or oxygen.

    o Determine if oxygen therapy is

    required and prescribe it.

    o Place a high-alert allergy band

    on the patient and mark it

    MULTIPLE CHEMICAL

    SENSITIVITY (MCS).

    o Educate the caregiver(s) to the

    patient's condition of MCS.

    o Discuss diet needs of patient

    and indicate on diet order that

    the diet is a special-needs diet

    for MCS. Only pure food should

    be served that do not contain

    preservatives, dyes, colorings,

    MSG, aspartame, or other GRAS

    foods (e.g., margarine).

    o Consult a dietician for dietary

    needs; retain dietary

    requirements in the patient's

    medical record for future

    reference.

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    7

    o Allow patient to supply his/her

    own tolerated food products

    and dietary supplements.

    o Assign a private room with

    negative pressure if available.

    Do not use a room that has

    been recently exposed to any

    type of fragrance or VOCs.

    Maintain patient isolation from

    other patients and their visitors

    at all times.

    o A room without carpeting is

    essential for the safety of the

    patient.

    o Change the linens on the bed

    that are fragrant-free (e.g.,

    without any Febreze fabric

    softener). Not all so-called

    scent-free products are toxin

    free!

    o Flag the patient's chart or other

    written information that he/she

    is chemically sensitive.

    o Whenever possible, take the

    patient's own medical supplies

    and equipment with them,

    including oxygen mask and

    tubing, medications, food and

    water, bedding, clothing, and

    soap. He/she may be sensitive

    to such items issued at a

    shelter, hospital, or clinic.

    o If drugs are administered

    (1) administer low doses with

    caution and keep them as

    simple and as minimal as

    possible;

    (2) use IV fluid bottled in glass

    without dextrose if possible

    (many persons react to corn-

    based dextrose);

    (3) capsules are generally better

    than tablets because they have

    fewer binders, fillers, and dyes;

    (4) if administering anesthesia,

    use short-acting regional rather

    than general anesthesia

    whenever possible and avoid

    the use of halogenated gas

    anesthetics.

    o Consult with the patient's

    environmental physician or

    acupuncturist if possible.

    o If the patient is taken to an

    emergency shelter or a hospital,

    help protect him/her from air

    pollution. Some suggestions

    (1) avoid placing the patient in

    rooms with recent pesticide

    sprays, strong scented

    disinfectants, cleaners, new

    paint or carpet, other recent

    remodeling, a recent patient

    wearing any fragrance;

    (2) place a sign on the door,

    stating the patient inside has

    MCS; and add ""Check at the

    nurses' station before entering

    the patient's room";

    (3) assign caregivers* who are

    not wearing fragrances (e.g.,

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    8

    perfume, fabric softener,

    Febreze on clothes, and who do

    not smoke);

    (4) allow the patient to wear a

    mask or respirator, nebulizer,

    use oxygen mask, or an air

    filter, or open a window as

    needed;

    (5) keep the door to the

    patient's room closed

    (6) reduce time the patient

    spends in other parts of the

    hospital, if possible, by

    performing as many procedures

    and evaluations as possible in

    his/her room;

    (7) transport patient with P95

    mask or personal respirator.

    * Caregivers: Staff caring for

    patient is to refrain at all times

    from wearing perfumes,

    scented lotions, hair spray,

    scented shampoo, deodorants,

    or scented products and use

    only unscented soap to wash

    their hands. Staff should also

    be aware that the laundry

    soaps and fabric softeners

    they use to wash their

    uniforms will affect the patient

    and should not use these

    products when caring for any

    patient with MCS! In fact, all

    members of the medical team

    should be fragrance-free,

    especially in regards to

    scented clothing, colognes, and

    the like.

    o Obtain Purple Nitrile Medical

    Exam Powder Free Glove Kit and

    place in room.

    o Do not use any Sharpie writing

    instruments or the like that

    have a strong odor.

    o Order a bottle of hydrogen

    peroxide to use as skin prep for

    IV initiations and phlebotomies.

    o If patient requires oxygen, open

    tubing, mask, or prongs

    package, "air out the item(s)

    before use with patient. Wipe

    the mask/prongs, and tubing

    with hydrogen peroxide and

    flush the tubing with oxygen or

    medical air prior to applying to

    patient. These actions are

    necessary to dissipate the scent

    of the plastic.

    o Keep the use of plastic to a

    minimum. Use paper tape

    instead of plastic tape.

    o Allow the patient, or provide,

    purified water for drinking.

    o Do not allow open containers

    with chemical to sit in the room.

    o No plants, flowers, magazines,

    newspapers are to be placed in

    the patient's room as they emit

    VOCs.

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    9

    o Whenever possible, ensure that

    the air is fresh (not artificially

    "fresh").

    o Utilize charcoal and baking

    soda to absorb and remove

    odors from the room. Open

    windows if possible.

    o Communicate and cooperate

    with the patient whenever

    possible as the patient generally

    knows what will help.

    o Observe the patient for the

    following symptoms

    o fatigue

    o memory loss

    o depression

    o nervousness

    o lack of motivation

    o visual problems

    o hearing problems

    o dizziness

    o sleep disorders

    o edema

    o inflammation of head

    tissue

    o syncope

    o spastic muscles (.2

    mEq/kg of magnesium

    over a 4-hour period daily

    may relieve spasms)

    o pulling parathesias

    o hypoesthesia

    o hyperventilation

    o seizures

    o asthma

    o severe anaphylaxis

    o disorientation

    o confusion

    o irritability

    o hoarseness

    o loss of coordination

    o loss of logic sequencing

    ability

    o shortness of breath

    o headache

    o chest pain

    o joint pain

    o digestive difficulties

    o tingling sensations in any

    part of the body

    o numbness of extremities

    o digestive difficulties

    o cold or heat sensitivity

    o rashes

    o nausea

    o sinusitis

    o rhinitis

    o pallor

    o anemia

    o hives

    o any other symptom

    Report to physician any signs

    and symptoms exhibited by

    patient.

    o In case of surgery, test Betadine,

    tape, and suture material 48

    hours prior to surgery to

    observe any adverse reaction.

    PRE-OP PROCEDURES

    o Wash down operating room

    with water and baking soda

    solution to remove disinfectant

    and pesticide odors.

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    10

    o Ensure that the patient has been

    prepared for surgery by

    lowering his/her total load of

    chemical exposures and

    increasing his/her intake of

    antioxidants, vitamins, and

    minerals. High levels of vitamin

    C before and during surgery

    (1 to 4 grams every four hours)

    helps to tolerate chemical

    overload.

    PRE-OP MEDICATIONS

    o No oral medication if possible.

    Avoid antihistamines and

    steroids if possible. Benadryl or

    an injection of 0.4 to 0.6 ml of

    IM atropine may be used to

    prevent excess secretions. Also,

    Atarax is usually safe. Usually,

    atropine or morphine-demerol

    compounds are sufficient for

    pain control. To alkalinize

    stomach contents to reduce

    problems with aspiration

    pneumonitis, use Akla Seltzer

    (without aspirin).

    For intravenous fluids, use IV

    0.45 normal saline in glass

    bottles, not plastic. Soft

    plastics, such as those used for

    IV drips and blood bags contain

    phthalates, which include many

    toxic chemicals such as

    hormone disrupters. These

    chemicals leach into the IV

    solution and can cause

    reactions in the patient with

    MCS. Glass bottled 45 NS

    available from Merit

    Pharmaceuticals ((800) 696-

    3748). If dextrose or Ringer's

    solution is used, observe for a

    reaction due to its corn content.

    For fructose and invert sugars,

    contact company beforehand to

    check formulations and sources.

    ANESTHESIA

    o Do not test anesthetic drugs

    before use.

    o All drugs should be checked for

    preservatives.

    o Sodium penathol, Versad,

    Phyentanyl (long-acting opiod)

    are recommended drugs for

    induction and maintenance of

    anesthsesia.

    o The basis for anesthesia to work

    well

    (1) the patients inhales 100%

    oxygen for five minutes;

    (2) Bolus of sodium pentothal or

    other short-acting barbiturate is

    used for induction;

    (3) followed by curare (a long-

    acting morphine compound)

    and a long-acting scopolamine

    compound. Succinyl choline

    chloride (Anectine) may also be

    used to paralyze. Sublimaze

    and Innovar can be used to

    obliterate memory.

    o For shorter procedures, the

    patient may use the Brevitol

    drip.

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    11

    o Diprovan is recommended for

    induction and/or regional

    anesthesia.

    o Use local anesthetics such as

    preservative-free and

    epinephrine-free xylocaine or

    carbocaine whenever possible.

    No halogenated hydrocarbons

    (Fluothane, Ethrane, Penthrane).

    The patient can get dramatically

    worse with gas anesthetics. If

    recovery occurs, it may involve

    several days of recovery.

    o Avoid inhaled anesthetic, if at

    all possible, since the

    fluorinated hydrocarbons and

    nitrous oxide are known to be

    immune-suppressants. If

    required, nitrous oxide is to be

    used only in as limited a level as

    is possible.

    SURGERY

    o Do not use any dyes.

    o Safe sutures are silk, cotton,

    gut-lamb. Avoid synthetics.

    o Recommended lab work for

    surgeryCBC, urinalysis, SMA

    20, liver function.

    POST-SURGERY

    o Antibiotics given intravenously

    provoke fewer reactions than

    orally administered antibiotics.

    o In-line intravenous filters

    should be used for higher

    tolerances.

    o Use TENS unit or acupuncture

    for pain control. Vicodan may

    be okay for pain.

    FURTHER NOTES/MODIFICATIONS

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    12

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    _____________________________________

    THE INFORMATION PROVIDED IS

    NOT INTENDED TO BE A

    SUBSTITUTE FOR A PHYSICIAN'S

    CARE OR TREATMENT. CONSULT

    WITH THE PHYSICIAN BEFORE

    ACTING ON ANY OF THE

    RECOMMENDATIONS. THIS DRAFT

    PROTOCOL IS PROVIDED IN THE

    ABSENCE OF A PROTOCOL THAT

    SPECIFICALLY MEETS THE NEEDS OF

    A PERSON WITH MULTIPLE

    CHEMICAL SENSITIVITY.

    IN FACT, THIS IS A CALL FOR AN

    OFFICIAL PROTOCOL. THE CDC

    NEEDS TO RECOGNIZE MCS AS A

    SERIOUS PUBLIC HEALTH CONCERN.

    According to a research study in 2011,

    ninety physicians practicing in the

    State of Virginia responded to a mail

    survey regarding MCS, over half

    believed chemical sensitivity to be a

    combination of medical ("a chemical

    exposure and genetics") and

    psychological condition (resultant

    response could be "depression,

    generalized anxiety, posttraumatic

    stress disorder, hopelessness"),

    slightly skewed towards physiological

    etiology. No physician endorsed a

    purely psychological etiology.

    The following statement should be

    taken into consideration regarding a

    June 2008 report published in "The

    Journal of Environmental Health" on

    "The Challenges of Multiple Chemical

    Sensitivity" which noted the following:

    Regardless of whether MCS is a

    legitimate physiologic disease process

    or not, giving it due consideration is a

  • PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY

    PROPOSED DRAFT FOR DISCUSSION PURPOSES

    13

    useful exercise for the public health

    community. If proven scientifically

    valid, MCS would significantly affect

    public health in general and

    environmental health specifically. MCS

    could fundamentally alter our

    understanding of pathophysiology,

    affecting disease research design and

    disease prevention measures. On a

    much broader level, the government,

    private sector, consumers, and general

    population would be engaged in a

    partnership that would benefit all of

    public health. A nimble, adaptable

    public health infrastructure benefits by

    considering MCS and the state of

    environmental health. It is an

    important exercise to consider these

    implications and the ability of public

    health to respond. A public health

    community that is unable or unwilling

    at a minimum to contemplate

    paradigm-altering possibilities neglects

    its duty. With such significant

    implications, neglect would be

    insensitive.

    Last but not least, every person with

    MCS symptoms varies in severity as

    well as symptoms due to a particular

    chemical exposure. Some persons

    have been suffering for a long time or

    some are recently aware of certain

    sources that are causing symptoms.

    Find out if the person has had/has

    extreme difficulties with any specific

    chemical exposures. One person's

    extreme may not be that of another's.

    There cannot be any generalization of

    MCS beyond the consensus criteria for

    diagnosis. For an example, a person a

    severe condition may not even be able

    to tolerate an ink pen in her/his

    surroundings. The symptoms may

    vary according to the possible

    multiple organs that may be afflicted.

    It is vital to check a person's organ

    health (e.g., heart, spleen, kidneys,

    lungs, liver, skin).

    Compiled from various online sources

    (October 18, 2014)